|
Volumn 61, Issue 2, 2001, Pages 163-166
|
Interpretation of antibacterial susceptibility reports: In vitro versus clinical break-points
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMINOGLYCOSIDE ANTIBIOTIC AGENT;
AMOXICILLIN;
AMPICILLIN;
ANTIINFECTIVE AGENT;
AZITHROMYCIN;
BETA LACTAM ANTIBIOTIC;
CLARITHROMYCIN;
GENTAMICIN;
MACROLIDE;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
ANTIBACTERIAL ACTIVITY;
ANTIBIOTIC SENSITIVITY;
AREA UNDER THE CURVE;
DRUG EFFICACY;
DRUG SAFETY;
DRUG SPECIFICITY;
HUMAN;
INFECTION;
LABORATORY TEST;
MINIMUM INHIBITORY CONCENTRATION;
REVIEW;
STREPTOCOCCUS INFECTION;
ANTI-BACTERIAL AGENTS;
BACTERIA;
COLONY COUNT, MICROBIAL;
DRUG RESISTANCE, MICROBIAL;
HUMANS;
MICROBIAL SENSITIVITY TESTS;
STREPTOCOCCUS;
|
EID: 0035091122
PISSN: 00126667
EISSN: None
Source Type: Journal
DOI: 10.2165/00003495-200161020-00001 Document Type: Review |
Times cited : (7)
|
References (14)
|